tiprankstipranks
Trending News
More News >
Buy Rating on Mirum Pharmaceuticals: Promising Phase 2b VANTAGE Study Results and Strong Market Potential
PremiumRatingsBuy Rating on Mirum Pharmaceuticals: Promising Phase 2b VANTAGE Study Results and Strong Market Potential
2M ago
Mirum’s volixibat shows ‘best-in-class potential,’ says Citi
Premium
The Fly
Mirum’s volixibat shows ‘best-in-class potential,’ says Citi
2M ago
Mirum Pharmaceuticals price target raised to $76 from $74 at Citizens JMP
Premium
The Fly
Mirum Pharmaceuticals price target raised to $76 from $74 at Citizens JMP
2M ago
Mirum Pharmaceuticals receives FDA approval for Livmarli tablet formulation
PremiumThe FlyMirum Pharmaceuticals receives FDA approval for Livmarli tablet formulation
3M ago
Strategic Advancements and Market Potential Drive Buy Rating for Mirum Pharmaceuticals
Premium
Ratings
Strategic Advancements and Market Potential Drive Buy Rating for Mirum Pharmaceuticals
3M ago
Mirum Pharmaceuticals partner Takeda receives approval for Livmarli in Japan
Premium
The Fly
Mirum Pharmaceuticals partner Takeda receives approval for Livmarli in Japan
3M ago
Mirum Pharmaceuticals price target raised to $55 from $50 at Baird
PremiumThe FlyMirum Pharmaceuticals price target raised to $55 from $50 at Baird
4M ago
Mirum Pharmaceuticals: Strong Financial Performance and Promising Pipeline Drive Buy Rating
Premium
Ratings
Mirum Pharmaceuticals: Strong Financial Performance and Promising Pipeline Drive Buy Rating
4M ago
Promising Growth and Strategic Positioning Make Mirum Pharmaceuticals a Compelling Buy
Premium
Ratings
Promising Growth and Strategic Positioning Make Mirum Pharmaceuticals a Compelling Buy
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100